B. Urbero

发表

Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end users

F. Dhombres, A. Olry, A. Rath, 2012, Human mutation.

OntoOrpha : an ontology to support the editing and audit of rare diseases knowledge in Orphanet CONFERENCE

F. Dhombres, J. Charlet, A. Olry, 2016 .

OntoOrpha : An Ontology to Support the Editing and Audit of Knowledge of Rare Diseases in ORPHANET

F. Dhombres, J. Charlet, A. Olry, 2014 .

Allogeneic recognition of class I molecules: Anti‐H‐2Ld repertoire of H‐2b mice includes T cells recognizing mutant class II H‐2b (Abm12) molecules

B. Urbero, M. Pla, B. Frangoulis, 1993, European journal of immunology.

Expression of the release factor eRF1 (Sup45p) gene of higher eukaryotes in yeast and mammalian tissues.

I. Stansfield, M. Tuite, B. Urbero, 1997, Biochimie.

The Absence of Human β2-microglobulin Increasesthe Occurrence of Ankylosing Enthesopathy in HLA-B27 Transgenic Mice

B. Urbero, M. Pla, M. Chopin, 2013, Clinical Rheumatology.

Biochemical and functional characteristics of soluble MHC molecules derived from H-2Ld/Q10d chimeric gene.

B. Urbero, M. Pla, M. Kress, 1993, Tissue antigens.

OntoOrpha: An Ontology to Support Edition and Audit of Knowledge of Rare Diseases in ORPHANET

Jean Charlet, Ferdinand Dhombres, Rémy Choquet, 2011, ICBO.

[Use of a directory of specialized services and guidance in the healthcare system: the example of the Orphanet database for rare diseases].

B. Urbero, S. Aymé, H. Nabarette, 2006, Revue d'epidemiologie et de sante publique.

[Information on rare diseases: the Orphanet project].

S Aymé, B Urbero, D Oziel, 1998, La Revue de medecine interne.